General Information of Drug-Metabolizing Enzyme (DME ID: DME0061)
DME Name Sulfotransferase 1E1 (SULT1E1), Homo sapiens DME Info
UniProt ID
ST1E1_HUMAN
EC Number    EC: 2.8.2.4     (Click to Show/Hide the Complete EC Tree)
Transferase
Sulfotransferase
Sulfotransferase
EC: 2.8.2.4
Lineage    Species: Homo sapiens     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Interactome
Disease Specific Interactions between Host Protein and DME (HOSPPI)
      ICD Disease Classification Healthy
               ICD-11: Healthy Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Non-coding RNA regulation
                            hsa-miR-199a-5p Health Suppression
miRBase ID
MIMAT0000231
Interaction Name hsa-miR-199a-5p--SULT1E1 regulation [1]
Studied Cell Lines Human dermal microvascular endothelial cells
Description hsa-miR-199a-5p is reported to suppress SULT1E1 mRNA translation by binding to the 3' untranslated region (3'UTR) of SULT1E1 mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Sulfotransferase 1E1.
      ICD Disease Classification 02 Neoplasms
               ICD-11: 2C60 Breast cancer Click to Show/Hide the Full List of HOSPPI:        2 HOSPPI
                     Transcription-factor regulation
                            TF factor AP-2 gamma (TFAP2C) Breast cancer Activation
Uniprot ID
AP2C_HUMAN
Interaction Name TFAP2C-SULT1E1 interaction [2]
Studied Cell Lines MCF10A and MCF7 cell lines
Ensembl ID
ENSG00000087510
Description TF factor AP-2 gamma (TFAP2C) is reported to activate the transcription of SULT1E1 gene, which leads to an increased expression of the drug-metabolizing enzyme Sulfotransferase 1E1. As a result, the interaction between TFAP2C and SULT1E1 can activate the drug-metabolizing process of Sulfotransferase 1E1.
                            TF factor AP-2-alpha (TFAP2A) Breast cancer Activation
Uniprot ID
AP2A_HUMAN
Interaction Name TFAP2A-SULT1E1 interaction [2]
Studied Cell Lines MCF10A and MCF7 cell lines
Ensembl ID
ENSG00000137203
Description TF factor AP-2-alpha (TFAP2A) is reported to activate the transcription of SULT1E1 gene, which leads to an increased expression of the drug-metabolizing enzyme Sulfotransferase 1E1. As a result, the interaction between TFAP2A and SULT1E1 can activate the drug-metabolizing process of Sulfotransferase 1E1.
      ICD Disease Classification 16 Genitourinary system diseases
               ICD-11: GB22 Hypertrophy of breast Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Histone modification
                            Histone deacetylases (HDACs) Hypertrophy of breast Repression
Uniprot ID
HDAC1_HUMAN
Interaction Name HDACs-SULT1E1 interaction [3]
Studied Cell Lines MCF10A lineage cell line
Description Histone deacetylases (HDACs) are reported to deacetylate the SULT1E1 gene and thereby repress the transcriptional activity of the drug-metabolizing enzyme Sulfotransferase 1E1. As a result, the interaction between HDACs and SULT1E1 can inhibit the drug-metabolizing process of Sulfotransferase 1E1.
References
1 The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway. J Biol Chem. 2012 Nov 30;287(49):41032-43.
2 AP2 Transcription Factors Regulate Expression of CRABPII in hormone responsive breast carcinoma. J Surg Res. 2007 Mar;138(1):71-8.
3 Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression. Breast Cancer Res Treat. 2010 Feb;120(1):35-45.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.